Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Erratum: Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy.

Biagioni A, Laurenzana A, Margheri F, Chillà A, Fibbi G, Del Rosso M.

J Biol Eng. 2019 May 2;13:37. doi: 10.1186/s13036-019-0169-0. eCollection 2019.

2.

EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells.

Laurenzana A, Margheri F, Biagioni A, Chillà A, Pimpinelli N, Ruzzolini J, Peppicelli S, Andreucci E, Calorini L, Serratì S, Del Rosso M, Fibbi G.

EBioMedicine. 2019 Jan;39:194-206. doi: 10.1016/j.ebiom.2018.12.024. Epub 2019 Jan 2.

3.

Delivery systems of CRISPR/Cas9-based cancer gene therapy.

Biagioni A, Laurenzana A, Margheri F, Chillà A, Fibbi G, So M.

J Biol Eng. 2018 Dec 18;12:33. doi: 10.1186/s13036-018-0127-2. eCollection 2018. Review. Erratum in: J Biol Eng. 2019 May 2;13:37.

4.

The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.

Andreucci E, Ruzzolini J, Peppicelli S, Bianchini F, Laurenzana A, Carta F, Supuran CT, Calorini L.

J Enzyme Inhib Med Chem. 2019 Dec;34(1):117-123. doi: 10.1080/14756366.2018.1532419.

5.

Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8.

Menicacci B, Margheri F, Laurenzana A, Chillà A, Del Rosso M, Giovannelli L, Fibbi G, Mocali A.

J Gerontol A Biol Sci Med Sci. 2018 Jul 31. doi: 10.1093/gerona/gly175. [Epub ahead of print]

PMID:
30084946
6.

Recommendations for In Vitro and In Vivo Testing of Magnetic Nanoparticle Hyperthermia Combined with Radiation Therapy.

Spirou SV, Costa Lima SA, Bouziotis P, Vranješ-Djurić S, Efthimiadou EΚ, Laurenzana A, Barbosa AI, Garcia-Alonso I, Jones C, Jankovic D, Gobbo OL.

Nanomaterials (Basel). 2018 May 6;8(5). pii: E306. doi: 10.3390/nano8050306. Review.

7.

Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.

Chillà A, Margheri F, Biagioni A, Del Rosso M, Fibbi G, Laurenzana A.

J Exp Clin Cancer Res. 2018 Apr 3;37(1):74. doi: 10.1186/s13046-018-0742-2.

8.

One pot environmental friendly synthesis of gold nanoparticles using Punica Granatum Juice: A novel antioxidant agent for future dermatological and cosmetic applications.

Gubitosa J, Rizzi V, Lopedota A, Fini P, Laurenzana A, Fibbi G, Fanelli F, Petrella A, Laquintana V, Denora N, Comparelli R, Cosma P.

J Colloid Interface Sci. 2018 Jul 1;521:50-61. doi: 10.1016/j.jcis.2018.02.069. Epub 2018 Mar 9.

PMID:
29549765
9.

Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH.

Ruzzolini J, Peppicelli S, Andreucci E, Bianchini F, Margheri F, Laurenzana A, Fibbi G, Pimpinelli N, Calorini L.

Cancer Lett. 2017 Nov 1;408:43-54. doi: 10.1016/j.canlet.2017.08.010. Epub 2017 Aug 18.

PMID:
28826720
10.

uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells.

Laurenzana A, Chillà A, Luciani C, Peppicelli S, Biagioni A, Bianchini F, Tenedini E, Torre E, Mocali A, Calorini L, Margheri F, Fibbi G, Del Rosso M.

Int J Cancer. 2017 Sep 15;141(6):1190-1200. doi: 10.1002/ijc.30817. Epub 2017 Jun 21.

11.

The acidic microenvironment as a possible niche of dormant tumor cells.

Peppicelli S, Andreucci E, Ruzzolini J, Laurenzana A, Margheri F, Fibbi G, Del Rosso M, Bianchini F, Calorini L.

Cell Mol Life Sci. 2017 Aug;74(15):2761-2771. doi: 10.1007/s00018-017-2496-y. Epub 2017 Mar 22. Review.

PMID:
28331999
12.

Chronic Resveratrol Treatment Inhibits MRC5 Fibroblast SASP-Related Protumoral Effects on Melanoma Cells.

Menicacci B, Laurenzana A, Chillà A, Margheri F, Peppicelli S, Tanganelli E, Fibbi G, Giovannelli L, Del Rosso M, Mocali A.

J Gerontol A Biol Sci Med Sci. 2017 Sep 1;72(9):1187-1195. doi: 10.1093/gerona/glw336.

PMID:
28329136
13.

Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma.

Margheri G, Zoppi A, Olmi R, Trigari S, Traversi R, Severi M, Bani D, Bianchini F, Torre E, Margheri F, Chillà A, Biagioni A, Calorini L, Laurenzana A, Fibbi G, Del Rosso M.

Oncotarget. 2016 Jun 28;7(26):39846-39860. doi: 10.18632/oncotarget.9511.

14.

Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium.

Margheri F, Ceruso M, Carta F, Laurenzana A, Maggi L, Lazzeri S, Simonini G, Annunziato F, Del Rosso M, Supuran CT, Cimaz R.

J Enzyme Inhib Med Chem. 2016;31(sup4):60-63. Epub 2016 Aug 15.

PMID:
27539792
15.

Endothelial Progenitor Cells as Shuttle of Anticancer Agents.

Laurenzana A, Margheri F, Chillà A, Biagioni A, Margheri G, Calorini L, Fibbi G, Del Rosso M.

Hum Gene Ther. 2016 Oct;27(10):784-791. doi: 10.1089/hum.2016.066. Review.

PMID:
27502560
16.

Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1.

Barcellos-de-Souza P, Comito G, Pons-Segura C, Taddei ML, Gori V, Becherucci V, Bambi F, Margheri F, Laurenzana A, Del Rosso M, Chiarugi P.

Stem Cells. 2016 Oct;34(10):2536-2547. doi: 10.1002/stem.2412. Epub 2016 Jul 4.

17.

HDAC1 controls CIP2A transcription in human colorectal cancer cells.

Balliu M, Cellai C, Lulli M, Laurenzana A, Torre E, Vannucchi AM, Paoletti F.

Oncotarget. 2016 May 3;7(18):25862-71. doi: 10.18632/oncotarget.8406.

18.

Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression.

Peppicelli S, Bianchini F, Toti A, Laurenzana A, Fibbi G, Calorini L.

Cell Cycle. 2015;14(19):3088-100. doi: 10.1080/15384101.2015.1078032.

19.

Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts.

Laurenzana A, Cencetti F, Serratì S, Bruno G, Japtok L, Bianchini F, Torre E, Fibbi G, Del Rosso M, Bruni P, Donati C.

J Mol Med (Berl). 2015 Oct;93(10):1145-57. doi: 10.1007/s00109-015-1292-0. Epub 2015 May 9.

PMID:
25952146
20.

Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells.

Laurenzana A, Biagioni A, Bianchini F, Peppicelli S, Chillà A, Margheri F, Luciani C, Pimpinelli N, Del Rosso M, Calorini L, Fibbi G.

J Mol Med (Berl). 2015 Jul;93(7):783-94. doi: 10.1007/s00109-015-1266-2. Epub 2015 Feb 20.

PMID:
25694039

Supplemental Content

Loading ...
Support Center